PharmaLundensis AB:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:PharmaLundensis AB - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C11507
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:22
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:スウェーデン
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
PharmaLundensis AB (PharmaLundensis) is a pharmaceutical company that develops drugs for lung diseases. The company develops drugs for chronic obstructive pulmonary disease (COPD), chronic bronchitis and influenza-induced lung failure. It also develops EcoFilter, a system that that eliminates all the release of pharmaceutical drugs and multi-resistant bacteria in hospital waste water and removes all multi-resistant bacteria from hospital sewage pipes, thereby eliminating the risk of multi-resistant bacteria that are growing in the pipes can infect patients in the hospital wards. The company conducts research on lung physiology and pathology to ascertain pharmacological modification applications to treat pulmonary diseases. PharmaLundensis is headquartered in Lund, Sweden.

PharmaLundensis AB – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
PharmaLundensis AB, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
PharmaLundensis AB, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
PharmaLundensis AB, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
PharmaLundensis AB, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
PharmaLundensis AB, Medical Devices Deals, 2012 to YTD 2018 9
PharmaLundensis AB, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
PharmaLundensis AB, Pharmaceuticals & Healthcare, Deal Details 11
Equity Offering 11
PharmaLundensis to Raise USD1.2 Million in Rights Offering of Shares 11
PharmaLundensis Raises USD1 Million in Rights Offering of Shares 12
PharmaLundensis Raises USD0.9 Million in Public Offering of Shares 13
PharmaLundensis Raises USD0.4 Million in Public Offering of Shares 14
PharmaLundensis AB – Key Competitors 15
PharmaLundensis AB – Key Employees 16
PharmaLundensis AB – Locations And Subsidiaries 17
Head Office 17
Recent Developments 18
Financial Announcements 18
Feb 16, 2018: PharmaLundensis: Financial Statement 1 January 2017 to 31 December 2017 18
May 24, 2017: PharmaLundensis: Annual Report 2016 19
Other Significant Developments 21
Jul 13, 2017: Pharmalundensis: Valuation of the project’s economic potential 21
Appendix 22
Methodology 22
About GlobalData 22
Contact Us 22
Disclaimer 22

List of Tables
PharmaLundensis AB, Pharmaceuticals & Healthcare, Key Facts 2
PharmaLundensis AB, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
PharmaLundensis AB, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
PharmaLundensis AB, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
PharmaLundensis AB, Deals By Therapy Area, 2012 to YTD 2018 8
PharmaLundensis AB, Medical Devices Deals, 2012 to YTD 2018 9
PharmaLundensis AB, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
PharmaLundensis to Raise USD1.2 Million in Rights Offering of Shares 11
PharmaLundensis Raises USD1 Million in Rights Offering of Shares 12
PharmaLundensis Raises USD0.9 Million in Public Offering of Shares 13
PharmaLundensis Raises USD0.4 Million in Public Offering of Shares 14
PharmaLundensis AB, Key Competitors 15
PharmaLundensis AB, Key Employees 16

List of Figures
PharmaLundensis AB, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
PharmaLundensis AB, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
PharmaLundensis AB, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
PharmaLundensis AB, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
PharmaLundensis AB, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
PharmaLundensis AB, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
PharmaLundensis AB, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
PharmaLundensis AB, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
PharmaLundensis AB, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[PharmaLundensis AB:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • BerGenBio ASA (BGBIO)-製薬・医療分野:企業M&A・提携分析
    Summary BerGenBio ASA (BerGenBio) is a developer of drugs for aggressive and drug resistant cancers. The company develops epithelial-mesenchymal transition inhibitors for acquired cancer drug-resistance and metastasis. Its BGB324 finds application in the treatment of drug resistant chronic myeloid l …
  • CapitaLand Limited:企業のM&A・事業提携・投資動向
    CapitaLand Limited - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's CapitaLand Limited Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), d …
  • PZ Cussons Nigeria Plc:企業の戦略・SWOT・財務情報
    PZ Cussons Nigeria Plc - Strategy, SWOT and Corporate Finance Report Summary PZ Cussons Nigeria Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • IndigoVision Group plc (IND):企業の財務・戦略的SWOT分析
    Summary IndigoVision Group plc (IndigoVision) is a developer, manufacturer and distributor of end-to-end IP security management systems. The company’s products include management software, cameras and encoders, specialized cameras, body worn video, integration and recorders. Its camera and encoder’s …
  • Imperial Dax Company, Inc:企業の戦略・SWOT・財務分析
    Imperial Dax Company, Inc - Strategy, SWOT and Corporate Finance Report Summary Imperial Dax Company, Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • NBN Co Ltd:企業の戦略的SWOT分析
    NBN Co Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. T …
  • Carl Zeiss Meditec AG (AFX)-医療機器分野:企業M&A・提携分析
    Summary Carl Zeiss Meditec AG (Carl Zeiss Meditec), a division of Carl Zeiss AG, an integrated medical technology company which operates in the fields of ophthalmology, neuro/ENT surgery and surgical ophthalmology. It provides comprehensive packages of solutions for the diagnosis and treatment of ey …
  • ONEOK Partners LP (OKS)-石油・ガス分野:企業M&A・提携分析
    Summary ONEOK Partners, L.P. (ONEOK Partners), a subsidiary of Oneok, Inc., is a midstream energy company. The company carries out gathering, processing, and storage and transportation of natural gas. It operates through master limited partnerships. ONEK Partners owns natural gas liquids (NGL) syste …
  • Plains All American Pipeline LP (PAA):企業の財務・戦略的SWOT分析
    Plains All American Pipeline LP (PAA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths an …
  • EndoStim Inc-医療機器分野:企業M&A・提携分析
    Summary EndoStim Inc (EndoStim) is a medical device company that offers therapeutic solutions. The company develops and commercializes a neurostimulation system for the treatment of severe gastroesophageal reflux disease. It concentrates on the treatment of gastroesophageal reflux disease through el …
  • RH Petrogas Ltd (T13):企業の財務・戦略的SWOT分析
    Summary RH Petrogas Ltd (RH Petrogas) is an oil and gas company that explores, develops and produces oil and gas resources. The company’s properties include FUYU 1 block, Basin and Island PSC, and SK331 PSC. Its FUYU 1 block property is located in south-east of the Fuyu oilfield in the Jilin provinc …
  • Molinos Rio de la Plata SA (MOLI3):企業の財務・戦略的SWOT分析
    Molinos Rio de la Plata SA (MOLI3) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • Pulmatrix Inc (PULM):製薬・医療:M&Aディール及び事業提携情報
    Summary Pulmatrix Inc (Pulmatrix), formerly Ruthigen Inc is a clinical stage biopharmaceutical company that develops inhaled therapeutic products intended for prevention and treatment of respiratory diseases and infections. The company develops its pipeline product using its proprietary inhaled smal …
  • Methodist Le Bonheur Healthcare-製薬・医療分野:企業M&A・提携分析
    Summary Methodist Le Bonheur Healthcare (Methodist Healthcare) is a healthcare service provider that offers patient care services. The center offers home health services through its hospitals. Its services include invasive spine surgery, education and counseling, cancer treatment and support, infusi …
  • Avebe U.A.:企業の戦略的SWOT分析
    Avebe U.A. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. T …
  • Hermes International SA:企業の戦略・SWOT・財務情報
    Hermes International SA - Strategy, SWOT and Corporate Finance Report Summary Hermes International SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • California Resources Corp (CRC):石油・ガス:M&Aディール及び事業提携情報
    Summary California Resources Corp (CRC) is an oil and gas company that explores for, produces, processes, gathers, and markets crude oil, natural gas and natural gas liquids. It has conventional and unconventional assets across major oil and gas basins such as San Joaquin, Los Angeles, Ventura and S …
  • SSP Group Ltd:企業の戦略・SWOT・財務分析
    SSP Group Ltd - Strategy, SWOT and Corporate Finance Report Summary SSP Group Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Omnicom Group Inc. (OMC):企業の財務・戦略的SWOT分析
    Omnicom Group Inc. (OMC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • miacom diagnostics GmbH:製品パイプライン分析
    Summary miacom diagnostics GmbH (miacom) is a molecular diagnostic company that develops and distributes molecular diagnostic tests. The company offers products such as hemoFISH, which identifies sepsis-related pathogens directly from positive blood culture bottles; respiFISH that identifies pathoge …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆